Evidence map›Paper›PMID 34667575›Full record

ArticleChemical science2021

A direct-to-biology high-throughput chemistry approach to reactive fragment screening.

Ross P Thomas, Rachel E Heap, Francesca Zappacosta, Emma K Grant, Peter Pogány, Stephen Besley, David J Fallon, Michael M Hann, David House, Nicholas C O Tomkinson and 1 more

Abstract read
In one paragraph

Article in Chemical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Early-stage drug discovery in a new-generation ultrahigh-throughput mass spectrometry platform.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Methods to accelerate PROTAC drug discovery.The Biochemical journal · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ross P ThomasGlaxoSmithKline Gunnels Wood Road Stevenage Hertfordshire SG1 2NY UK jacob.x.bush@gsk.com.
Rachel E HeapGlaxoSmithKline South Collegeville Road Collegeville PA 19426 USA.
Francesca ZappacostaGlaxoSmithKline South Collegeville Road Collegeville PA 19426 USA.
Emma K GrantGlaxoSmithKline Gunnels Wood Road Stevenage Hertfordshire SG1 2NY UK jacob.x.bush@gsk.com.
Peter PogányGlaxoSmithKline Gunnels Wood Road Stevenage Hertfordshire SG1 2NY UK jacob.x.bush@gsk.com.ORCID https://orcid.org/0000-0003-3536-0746
Stephen BesleyGlaxoSmithKline Gunnels Wood Road Stevenage Hertfordshire SG1 2NY UK jacob.x.bush@gsk.com.
David J FallonGlaxoSmithKline Gunnels Wood Road Stevenage Hertfordshire SG1 2NY UK jacob.x.bush@gsk.com.
Michael M HannGlaxoSmithKline Gunnels Wood Road Stevenage Hertfordshire SG1 2NY UK jacob.x.bush@gsk.com.ORCID https://orcid.org/0000-0003-4360-9505
David HouseGlaxoSmithKline Gunnels Wood Road Stevenage Hertfordshire SG1 2NY UK jacob.x.bush@gsk.com.
Nicholas C O TomkinsonDepartment of Pure and Applied Chemistry, University of Strathclyde 295 Cathedral Street Glasgow G1 1XL UK.ORCID https://orcid.org/0000-0002-5509-0133
Jacob T BushGlaxoSmithKline Gunnels Wood Road Stevenage Hertfordshire SG1 2NY UK jacob.x.bush@gsk.com.ORCID https://orcid.org/0000-0001-7165-0092

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methods for rapid identification of chemical tools are essential for the validation of emerging targets and to provide medicinal chemistry starting points for the development of new medicines. Here, we report a screening platform that combines 'direct-to-biology' high-throughput chemistry (D2B-HTC) with photoreactive fragments. The platform enabled the rapid synthesis of >1000 PhotoAffinity Bits (HTC-PhABits) in 384-well plates in 24 h and their subsequent screening as crude reaction products with a protein target without purification. Screening the HTC-PhABit library with carbonic anhydrase I (CAI) afforded 7 hits (0.7% hit rate), which were found to covalently crosslink in the Zn

Identifiers

PMID34667575
PMCPMC8457371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.